Ottawa has answered. Most of it already existed.
On 19 August the Government of Canada tabled its formal response to House of Commons petition e-7076, which called for stronger action on Long COVID, post-vaccine injuries and related conditions. It acknowledges the harm. It does not commit to most of what was asked.
1,103 signatures, seven asks.
Petition e-7076 was initiated by Jennifer Armitage of Mission, British Columbia. It received 1,103 validated signatures and was presented in the House of Commons on 17 June 2026 by Brad Vis, MP for Mission—Matsqui—Abbotsford.
The petition described significant gaps in diagnosis, treatment, research, disability support and financial assistance. Among other measures, petitioners asked the federal government to:
- hold a national inquiry examining the long-term effects of Long COVID and post-vaccine injuries;
- develop national standards for diagnosis and care pathways;
- improve access to medical care beyond symptom management;
- provide disability support that reflects patients’ actual needs;
- provide financial assistance for treatments and daily living expenses;
- increase public awareness of Long COVID and reduce dismissal and stigma; and
- recognise and support the effects of chronic illness on families and caregivers.
The petition also argued explicitly that existing disability, medical and financial programs are insufficient.
Research, guidelines, and a network.
The response, signed by Health Minister Maggie Chi, begins by acknowledging the challenges faced by people living with Long COVID — referred to federally as Post COVID-19 Condition. It then highlights several existing federal initiatives.
- $9M over three years for the development and promotion of national clinical guidance, intended to provide evidence-based recommendations for assessing, managing and treating Long COVID.
- $20 million over five years, beginning in 2023, for Long COVID Web, the pan-Canadian research network funded through the Canadian Institutes of Health Research.
- CIHR-supported biomedical research, living evidence reviews and clinical trials investigating potential treatments and interventions.
- A grant awarded in early 2026 to a University of Alberta team led by Dr. Shokrollah Elahi, studying immune-system changes in Long COVID, including why women are disproportionately affected.
These are legitimate federal Long COVID investments. But most are not new measures announced in response to the petition.
The distance between the ask and the answer.
The most important part of the response may be the gap between what petitioners requested and what the government actually committed to doing. On our reading, the response contains:
- no commitment to a national inquiry into Long COVID;
- no new Long COVID funding announcement;
- no new national system for clinical care or specialist access;
- no national minimum standards governing what care Canadians should receive regardless of province or territory;
- no new federal disability or income-support measures specific to Long COVID;
- no financial assistance for the treatment costs and daily living expenses the petition identified; and
- no new mechanism for translating emerging evidence into treatment access for patients today.
That distinction matters. Research infrastructure and clinical guidance are important. But a clinical guideline is not itself a clinic, a specialist appointment, an approved treatment, disability income, or reimbursement for medical expenses.
This is our reading of the commitments actually contained in the response, not an assertion that Ottawa has formally rejected these measures.
One injury gets a compensation program. The other gets a research network.
Because e-7076 combines Long COVID with post-vaccine injuries, the response devotes substantial attention to the federal Vaccine Impact Assistance Program, which Ottawa took over directly on 1 April 2026. The response explains that eligible participants may receive:
- a vaccine injury indemnity — a one-time lump sum payment;
- income support — ongoing monthly income replacement;
- treatment and rehabilitation expenses — reimbursement for eligible costs not covered by other insurance; and
- death benefits, including funeral support.
For Long COVID, the same response describes research, guidelines and collaboration. It identifies no comparable federal program providing Long COVID patients with treatment reimbursement or condition-specific income replacement.
This does not diminish the importance of support for people with qualifying vaccine injuries. Both populations deserve recognition and assistance. But the contrast shows something real about federal policy: a defined compensation and expense-support mechanism exists for one category of health injury discussed in the petition, while the Long COVID answer remains centred on research, evidence development and guidance.
Canada knows more about Long COVID than it treats.
Canada has increasingly built the infrastructure needed to study this condition and describe how it should be managed. The unresolved question is how those investments are changing patients’ lives. For example:
- How many Canadians can now obtain a timely diagnosis?
- How long do patients wait for knowledgeable specialist care?
- Which evidence-supported pharmacological treatments are actually accessible?
- How many patients have gained access to care because of the national clinical guidelines?
- How many Canadians unable to work because of Long COVID receive adequate disability income?
- What treatment expenses are patients still paying themselves?
- Are patients in different provinces receiving meaningfully different levels of care?
The response does not provide these outcome measures. That makes it difficult to judge whether investments measured in dollars, research projects and guidelines have produced measurable improvements in diagnosis, treatment, disability support or financial security.
It is not the same as care.
Federal investment in Long COVID research remains essential. Canada needs biomedical research capable of identifying disease mechanisms, biomarkers and effective treatments. It needs rigorous clinical trials. It needs knowledgeable clinicians and evidence-based guidance.
But research cannot become a substitute for addressing the immediate needs of people who are already sick. A patient who has been unable to work for years cannot live on a research network. A guideline cannot help someone if there is no clinician available to implement it. And identifying promising treatments does not automatically make those treatments accessible.
The next stage of Canada’s Long COVID response should be judged not only by how much research is funded, but by whether Canadians can obtain diagnosis, treatment, knowledgeable medical care and sufficient economic support.
One question, and it has a number for an answer.
The federal response gives Canadians a much clearer picture of what Ottawa considers its Long COVID response to be. That makes a straightforward accountability question possible.
What measurable improvements have the federal government’s Long COVID investments produced in Canadians’ ability to obtain diagnosis, specialist care, treatment, disability support and income security?
The 19 August response documents important investments in research and guidance. It also makes clear how much remains unresolved between generating knowledge about Long COVID and delivering the care and support that people living with it need.
Long COVID Action Canada will keep tracking federal commitments and assessing whether public investments translate into measurable improvements for patients.
Source: House of Commons, Petition e-7076 — opened 29 January 2026, closed 29 May 2026 at 1,103 validated signatures, presented 17 June 2026 (Petition No. 451-01124), government response tabled 19 August 2026. Response by the Minister of Health, signed by Maggie Chi. Quoted figures and program details are taken from that response.